Max Healthcare Institute Receives Reclassification Request from Radiant Life Care Hospital Foundation

2 min read     Updated on 14 May 2026, 08:44 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Max Healthcare Institute Limited received a formal request on May 12, 2026, from Radiant Life Care Hospital Foundation (RLCHF) to reclassify from 'Promoter Group' to 'Public' category under Regulation 31A of SEBI (LODR) Regulations, 2015. The request was triggered by the sale of the entire equity stake held by Mr. Abhay Soi and Radiant Life Care Private Limited in RLCHF. Since RLCHF holds nil shares in the company, the reclassification will have no impact on the overall promoter and promoter group shareholding.

powered bylight_fuzz_icon
40210241

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute Limited has disclosed that it received a formal request on May 12, 2026, from Radiant Life Care Hospital Foundation (formerly known as 'Radiant Life Care Foundation'), referred to as RLCHF, seeking reclassification from the 'Promoter Group' to the 'Public' category. The request has been made in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was communicated to the stock exchanges on May 13, 2026, and signed by Dhiraj Aroraa, SVP - Company Secretary and Compliance Officer.

Background of the Reclassification Request

The reclassification request has been triggered by the sale of the entire equity stake held by Mr. Abhay Soi, a Promoter, and Radiant Life Care Private Limited, a Promoter Group entity, in RLCHF. As a result of this transaction, RLCHF no longer satisfies the definition of "Promoter Group" as specified under Regulation 2(1)(pp) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The key details of the reclassification request are summarised below:

Parameter: Details
Requesting Entity: Radiant Life Care Hospital Foundation (formerly Radiant Life Care Foundation)
Request Date: May 12, 2026
Reclassification From: Promoter Group
Reclassification To: Public Category
Applicable Regulation: Regulation 31A of SEBI (LODR) Regulations, 2015
Trigger Event: Sale of entire equity stake by Mr. Abhay Soi and Radiant Life Care Private Limited in RLCHF
RLCHF Shareholding in Company: Nil

Impact on Promoter Shareholding

As of the date of the disclosure, RLCHF does not hold any shares in Max Healthcare Institute Limited. Consequently, the proposed reclassification will not result in any change to the overall shareholding of the promoter and promoter group in the Company. This ensures that the corporate governance structure and promoter holding pattern remain unaffected by the proposed change in classification.

Next Steps and Regulatory Process

The reclassification request is scheduled to be placed before the Board of Directors of Max Healthcare Institute Limited at its forthcoming board meeting for consideration. The Company has stated that it will undertake all necessary steps and seek requisite approvals in compliance with Regulation 31A of the SEBI Listing Regulations. The disclosure has also been made available on the Company's website at www.maxhealthcare.in , in line with regulatory requirements.

The reclassification, once approved through the prescribed regulatory process, will formally reflect RLCHF's transition to the 'Public' category in the Company's shareholding disclosures.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
+1.14%-1.63%-3.39%-9.84%-14.92%+297.50%

How might the reclassification of RLCHF to the 'Public' category influence institutional investor sentiment and Max Healthcare's stock liquidity in the near term?

Could the sale of Mr. Abhay Soi's stake in RLCHF signal a broader strategic realignment or potential exit from Max Healthcare's promoter group, and what implications would that have for corporate governance?

Are there any other Promoter Group entities associated with Radiant Life Care that could potentially seek similar reclassification, and how might that affect Max Healthcare's promoter holding percentage?

Max Healthcare Institute
View Company Insights
View All News
like16
dislike

Max Healthcare Institute Allots 51,287 Equity Shares Under Employee Stock Option Scheme

2 min read     Updated on 02 May 2026, 05:15 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Max Healthcare Institute Limited's Nomination & Remuneration Committee approved the allotment of 51,287 equity shares under Employee Stock Option Scheme 2022 on May 1, 2026. The shares were issued at ₹350 per share with ₹340 premium to eligible employees, increasing the company's paid-up equity capital from ₹973,19,25,020 to ₹973,24,37,890. The allotment complies with SEBI regulations and detailed filing information has been submitted to BSE and NSE.

powered bylight_fuzz_icon
39196243

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute Limited has completed the allotment of 51,287 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The Nomination & Remuneration Committee approved this allotment on May 1, 2026, at 6:56 pm IST, as part of the company's employee incentive program.

Share Allotment Details

The allotment involves 51,287 equity shares with a face value of ₹10 each, issued as fully paid-up shares to eligible employees who exercised their vested stock options. The exercise price was set at ₹350 per equity share, with a premium of ₹340 per share.

Allotment Parameters: Details
Number of Shares: 51,287 equity shares
Face Value: ₹10 per share
Exercise Price: ₹350 per share
Premium: ₹340 per share
Allotment Date: May 1, 2026

Impact on Share Capital

The allotment has resulted in an increase in the company's paid-up equity share capital. The shares have been issued in dematerialized form with distinctive numbers ranging from 97,31,92,503 to 97,32,43,789.

Capital Structure: Pre-allotment Post-allotment
Number of Equity Shares: 97,31,92,502 97,32,43,789
Face Value: ₹10 ₹10
Paid-up Equity Capital: ₹973,19,25,020 ₹973,24,37,890

Regulatory Compliance and Filing Details

The allotment has been made in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company filed the initial statement under regulation 10(b) with the stock exchanges on September 29, 2022, receiving filing numbers DCS/IPO/MJ/ESOP-IP/2511/2022-23 from BSE and NSE/LIST/32765 from NSE.

Regulatory Information: Details
Filing Date: September 29, 2022
BSE Filing Number: DCS/IPO/MJ/ESOP-IP/2511/2022-23
NSE Filing Number: NSE/LIST/32765
ISIN Number: INE027H01010

Share Characteristics

The newly allotted equity shares are identical in all respects to the existing equity shares of the company. No lock-in provisions apply to these shares, and no listing fees are payable for this allotment. The company has noted that this allotment is not material in nature under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure regarding this allotment will be hosted on the company's website at www.maxhealthcare.in , ensuring transparency and compliance with regulatory requirements. The communication was signed by Dhiraj Aroraa, SVP - Company Secretary and Compliance Officer, and submitted to both BSE Limited and National Stock Exchange of India Limited.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
+1.14%-1.63%-3.39%-9.84%-14.92%+297.50%

What percentage of Max Healthcare's total ESOP pool has now been exercised, and how many options remain available for future employee allocations?

How might this employee stock option exercise activity signal employee confidence in Max Healthcare's growth prospects compared to industry peers?

Will Max Healthcare need to adjust its ESOP exercise price or introduce new tranches to remain competitive in attracting healthcare talent?

Max Healthcare Institute
View Company Insights
View All News
like15
dislike

More News on Max Healthcare Institute

1 Year Returns:-14.92%